Skip to main content

Month: April 2021

Konsolidator signs the first customer in Belgium

Press release no 5-2021 Søborg, April 26, 2021 Konsolidator signs the first customer in Belgium Konsolidator has signed its first customer in Belgium. This means that Konsolidator’s software is now being used by customers in 15 different countries across Europe, Africa, Asia, the Middle East, and North America.    The Belgium customer is a result of Konsolidator’s go-to-market plan that uses online marketing to drive interest and traffic to Konsolidator and that way allowing Konsolidator to market the software in new countries without a local presence.   “We are excited to engage the first customer in Belgium. We believe that Konsolidator will be well received in the Benelux and eventually we will make a greater effort to assist the finance professionals in the Benelux to become better through simplicity”, says CEO Claus Finderup...

Continue reading

Eik fasteignafélag hf.: Rafrænn aðalfundur

Hluthafar eru minntir á að aðalfundur Eikar fasteignafélags hf. sem fram fer kl. 16:00 í dag verður alfarið rafrænn. Hluthafar sem ekki hafa skráð sig en hyggjast taka þátt í fundinum eru beðnir að senda tölvupóst á stjornun@eik.is fyrir kl. 15:00 í dag með nafni, kennitölu, farsímanúmeri og netfangi auk afrits af persónuskilríkjum og umboði (ef við á).

Continue reading

Costamare Inc. Announces the Acquisition of the York Capital Majority Interest in Five 11,000 TEU Containerships with Long-Term Charters

MONACO, April 26, 2021 (GLOBE NEWSWIRE) — Costamare Inc. (the “Company”) (NYSE: CMRE) announced today the acquisition of York Capital’s 60% equity interest, on average, in five 11,000 TEU containerships, four of which were built in 2017 and one of which was built in 2016. The acquisition brings the Company’s ownership interest in these five vessels to 100%.

Continue reading

Human Insulin Market Size 2021 | Is Anticipated to Reach USD 27.71 Billion and Exhibit a CAGR of 3.4% by 2026

Pune, India, April 26, 2021 (GLOBE NEWSWIRE) — The global human insulin market size is anticipated to reach USD 27.71 billion by 2026. International Diabetes Federation (IDF) reported that around 425 million people across the world suffer from diabetes. This shows that the rising prevalence of diabetes is propelling growth in the market. Fortune Business Insights in a new report, predicts the market to exhibit a CAGR of 3.4% during the forecast period. In 2018, the market value stood at USD 21.26 billion in 2018. The adoption of delivery devices primarily for insulin administration is increasing, thus driving the market. Some of the other key players operating in the market are:Novo Nordisk A/S Eli Lilly and Company Boston Scientific Corporation Sanofi Boehringer Ingelheim International GmbH Biocon Tonghua Dongbao Pharmaceutical Julphar Wockhard Other...

Continue reading

Ørsted signs power purchase agreement with MSD

MSD enters into an agreement to purchase energy from the Armadillo Solar Center in Navarro County, Texas. With the PPA, Ørsted is extending its industrial customer base to the pharmaceutical industry. The Center is expected to be operational by early 2023. MSD, a biopharmaceutical company known as Merck & Co. Inc., Kenilworth New Jersey, in the US and Canada, has signed an agreement to purchase energy from the Armadillo Solar Center in Texas. “We’re happy to partner with MSD and expand our customer base to the pharmaceutical industry,” said Vishal Kapadia, Senior Vice President and Chief Commercial Officer of Onshore in Ørsted, continuing: “It’s exciting to join forces with them in their efforts to advance the use of carbon-free energy in the medical industry.” The Armadillo Solar Center will be based in Navarro County in Texas,...

Continue reading

Ørsted indgår elkøbsaftale med MSD

MSD indgår aftale om at købe energi fra Armadillo-solcelleanlægget i Navarro County i Texas i USA. Med denne elkøbsaftale (PPA) udvider Ørsted sin base af industrikunder til nu også at omfatte medicinalindustrien. Anlægget forventes at blive sat i drift i starten af 2023. MSD, en medicinalvirksomhed, der er kendt som Merck & Co. Inc., Kenilworth New Jersey, i USA og Canada, har indgået en aftale om at købe energi fra Ørsteds Armadillo-solcelleanlæg i Texas, USA. ”Vi er glade for at indgå dette samarbejde med MSD og udvide vores kundebase, så den nu også omfatter medicinalindustrien,” siger Vishal Kapadia, Senior Vice President og Chief Commercial Officer for Onshore i Ørsted. Han fortsætter: ”Vi ser frem til at samarbejde med dem i deres bestræbelser om at fremme brugen af CO2-fri energi i medicinalindustrien.” Armadillo-solcelleanlægget...

Continue reading

Non-invasive Prenatal Testing Market to Reach USD 13.16 Billion by 2028; Technological Intervention to Play a Massive Role in Growth, says Fortune Business Insights™

Pune, India, April 26, 2021 (GLOBE NEWSWIRE) — The global non-invasive prenatal testing (NIPT) market size is projected to reach USD 13.16 billion by the end of 2028. The presence of several large scale companies will have a positive impact on the growth of the market in the upcoming years. According to a report published by Fortune Business Insights, titled, “Non Invasive Prenatal Testing (NIPT) Market, 2021-2028,” the market was worth USD 3.48 billion in 2020 and will exhibit a CAGR of 18.1% during the forecast period, 2021-2028. Industry Developments: July 2019: Invitae announced that it will be acquiring Singular Bio, a company specializing in single-molecule cell-free DNA analysis. The collaboration will be aimed at developing non-invasive prenatal tests. Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/non-invasive-prenatal-testing-market-100998 List...

Continue reading

Blue Vision A/S – forlængelse af bankgæld og optagelse af konvertible lån

Dato: 26. april  2021 Årets meddelelse nr.: 13 Blue Vision A/S gav i resumeet til årsrapporten for 2020, offentliggjort den 31. marts 2021, blandt andet oplysning om, at selskabets prekære likviditetssituation ville blive søgt imødekommet ved yderligere kreditorforhandlinger samt kapitalfremskaffelse herunder i form af konvertible lån. Der kan således gives orientering om, at som et resultat af bestræbelserne – og ikke mindst værdsat velvilje blandt Blue Vision A/S’ samarbejdspartnere – har selskabet:indgået aftaler for så vidt angår bankgæld stor 8,5 mio. kr. således, at gælden tidligst forfalder i 2022,optaget konvertible lån på ca. kr. 3,0 mio. kr. jf. bemyndigelserne givet i vedtægternes paragraf 4.3.A og 4.3.B, indgået kreditoraftale for så vidt angår 2,4 mio. kr. således at forfaldsdatoen forlænges til primo...

Continue reading

O-I Glass Announces Agreement of Potential Plan of Reorganization for Paddock Subsidiary

PERRYSBURG, Ohio, April 26, 2021 (GLOBE NEWSWIRE) — O-I Glass, Inc. (“O-I Glass” or “O-I”) today announced that its wholly owned subsidiary, Paddock Enterprises, LLC (“Paddock”), has reached an agreement in principle for a consensual plan of reorganization under section 524(g) of the Bankruptcy Code. Paddock, the Official Committee of Asbestos Personal Injury Claimants (the “ACC”), and the legal representative for the future asbestos personal injury claimants (the “FCR”) all agreed to accept the terms of a mediator’s proposal regarding a potential consensual plan of reorganization for Paddock. O-I Glass supports the agreement among Paddock, the ACC and the FCR that follows a successful court-approved mediation process conducted by Kenneth Feinberg and the Honorable Layn R. Phillips in connection with Paddock’s ongoing Chapter 11...

Continue reading

Auxly Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Outlook for 2021

TORONTO, April 26, 2021 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX ‐ XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“), a consumer packaged goods company in the cannabis products market, today released its fourth quarter and full year 2020 financial results. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com. All amounts are Canadian dollars except common shares (“Shares”) and per Share amounts. 2020 HighlightsRecorded net revenues of $50.8 million in 2020, including $46.6 million in cannabis net revenues, an increase of 508% compared to 2019. Fourth quarter net Cannabis revenues of $18.3 million. Achieved the #1 LP position in Canada for Cannabis 2.0 product sales1 in 2020 with approximately 14% market share in the category. Expanded into the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.